Development of a papillary thyroid carcinoma in a patient while on high dosage ascorbic acid therapy
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 30 (3) , 305-308
- https://doi.org/10.1016/0009-2797(80)90053-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. II. Effects of vitamin CProstaglandins and Medicine, 1979
- The regulation of prostaglandin E1 formation: A candidate for one of the fundamental mechanisms involved in the actions of vitamin CMedical Hypotheses, 1979
- Acute Reactions to Mega Ascorbic Acid Therapy in Malignant DiseaseScottish Medical Journal, 1979
- Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancerProceedings of the National Academy of Sciences, 1978
- Relationships between ascorbic acid and serum proteins of the immune system.BMJ, 1977
- The orthomolecular treatment of cancerChemico-Biological Interactions, 1975
- The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancerChemico-Biological Interactions, 1974
- The orthomolecular treatment of cancer I. The role of ascorbic acid in host resistanceChemico-Biological Interactions, 1974
- Childhood thyroid carcinomaCancer, 1961
- CANCER OF THE THYROID: (SPECIAL ARTICLE)Journal of Clinical Endocrinology & Metabolism, 1950